COLLEGIUM PHARMACEUTICAL, INC - COLL

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G JANUS HENDERSON GROUP PLC 5.8% 1,825,651 View
May 15, 2026 SCHEDULE 13G/A Eventide Asset Management, LLC 4.5% 1,424,282 View
May 15, 2026 SCHEDULE 13G/A Finny Kuruvilla, M.D. Ph. D. 4.5% 1,424,282 View
May 15, 2026 SCHEDULE 13G/A Robin C. John 4.5% 1,424,282 View
May 14, 2026 SCHEDULE 13G/A Renaissance Technologies LLC 4.53% 1,469,449 View
May 14, 2026 SCHEDULE 13G/A Renaissance Technologies Holdings Corporation 4.53% 1,469,449 View
May 12, 2026 SCHEDULE 13G Integrated Core Strategies (US) LLC 4.7% 1,515,406 View
May 12, 2026 SCHEDULE 13G Millennium Management LLC 4.7% 1,519,500 View
May 12, 2026 SCHEDULE 13G Millennium Group Management LLC 4.7% 1,519,500 View
May 12, 2026 SCHEDULE 13G Israel A. Englander 4.7% 1,519,500 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Rubric Capital Management LP 4.73% 1,496,436 View
Feb 13, 2026 SCHEDULE 13G/A David Rosen 4.73% 1,496,436 View
Feb 13, 2026 SCHEDULE 13G/A Eventide Asset Management, LLC 5.9% 1,876,239 View
Feb 13, 2026 SCHEDULE 13G/A Finny Kuruvilla, M.D. Ph. D. 5.9% 1,876,239 View
Feb 13, 2026 SCHEDULE 13G/A Robin C. John 5.9% 1,876,239 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.